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Background:  Increasing serum levels of N-terminal prohormone brain natriuretic peptide (NTproBNP) are associated with worsening heart 
failure (HF) in adults. The role of NTproBNP in pediatric HF is not well established. In order to obtain unbias estimates of sensitivity and specificity, 
we performed a cross-validation of the predictive utility of NTproBNP as a biomarker for eventual cardiac transplant in children with dilated 
cardiomyopathy (DCM).
Methods:  A previously reported group of 36 patients with DCM (median age at diagnosis = 2.2 years, 39% male) was used as a calibration set 
in which an optimized cut-point for NTproBNP (i.e., 1000 pg/ml) as a clinical indicator of severely decreased functional status was determined. 
This decision rule was then applied to 34 new patients with the same diagnosis of DCM (median age at diagnosis = 6.5 years, 50% male) in 
whom the clinical end-point was the presence or absence of eventual transplantation. NTproBNP was measured at each clinic visit or throughout 
hospitalization as needed. Patients whose NTproBNP dropped below the 1000 pg/ml cut-point prior to their last serial measurement were 
considered “Predicted Non Transplant”.
Results:  Eleven of 13 transplanted patients were correctly predicted having NTproBNP constantly above 1000 pg/ml. Seventeen of the 21 Non-
Transplant patients showed a drop in NTproBNP below the cut-point and were correctly predicted as Non-Transplant. Calculated sensitivity remained 
high (0.85-0.92) and specificity was fair (0.67-0.81) under various classification schemes used for borderline cases.
Conclusions:  In children with HF, NTproBNP that remains above 1000 pg/ml over serial measurements are generally at increased risk for heart 
transplantation; although by itself such a value does not mandate such need. The results suggest that this value represents important additional 
information in the decision process. The low specificity is primarily a function of additional decision processes that intervene when a transplant 
becomes a possible option. The generalizability from functional status to the transplant situation was primarily due to the high correlation between 
the transplant and functional status outcomes (0.81).
